Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topcon 3D OCT-1 Maestro Optic Disc and RNFL Study: Agreement and Repeatability Comparison With the iVue

NCT02277119 is registered in ClinicalTrials.gov with Topcon Medical Systems, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02277119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topcon 3D OCT-1 Maestro Optic Disc and RNFL Study: Agreement and Repeatability Comparison With the iVue
Lead sponsor
Topcon Medical Systems, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
February 28, 2015
Enrollment
109 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

eyes with retinal diseases, glaucomatous eyes, normal healthy subjects with no known ocular diseases